Remove 2025 Remove Family Remove Family Practice Remove Manufacturing
article thumbnail

Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement

Physician's Weekly

TUESDAY, July 1, 2025 (HealthDay News) — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 in the Annals of Internal Medicine. Bruno Linetzky, M.D., All rights reserved.

article thumbnail

Zicam and Orajel Swabs Recalled for Possible Fungal Contamination

Physician's Weekly

THURSDAY, June 12, 2025 (HealthDay News) — Some nasal and baby teething swabs from Zicam and Orajel are being recalled across the country because they may be contaminated with fungus, U.S. Food and Drug Administration (FDA) after the manufacturer, Church & Dwight Co., health officials said. The recall was announced by the U.S.